These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 38059613)

  • 1. Low-dose diazoxide therapy in hyperinsulinaemic hypoglycaemia.
    Ng AY; Agrawal P; Vijayan R; Arya VB; Kapoor RR; Shah P
    Clin Endocrinol (Oxf); 2024 Feb; 100(2):140-142. PubMed ID: 38059613
    [No Abstract]   [Full Text] [Related]  

  • 2. Hyperinsulinaemic hypoglycaemia in deoxyguanosine kinase deficiency.
    Arya VB; Dhawan A; Kapoor RR
    Clin Endocrinol (Oxf); 2019 Dec; 91(6):900-903. PubMed ID: 31465631
    [No Abstract]   [Full Text] [Related]  

  • 3. Paradoxical hypoglycaemia associated with diazoxide therapy for hyperinsulinaemic hypoglycaemia.
    Ponmani C; Gannon H; Hussain K; Senniappan S
    Horm Res Paediatr; 2013; 80(2):129-33. PubMed ID: 23886961
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The evolving course of HNF4A hyperinsulinaemic hypoglycaemia--a case series.
    McGlacken-Byrne SM; Hawkes CP; Flanagan SE; Ellard S; McDonnell CM; Murphy NP
    Diabet Med; 2014 Jan; 31(1):e1-5. PubMed ID: 23796040
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ketotic hypoglycaemia in children with diazoxide responsive hyperinsulinism of infancy.
    Hussain K
    Eur J Pediatr; 2005 Jun; 164(6):387-90. PubMed ID: 15772812
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diazoxide-induced pulmonary hypertension in hyperinsulinaemic hypoglycaemia: Recommendations from a multicentre study in the United Kingdom.
    Chen SC; Dastamani A; Pintus D; Yau D; Aftab S; Bath L; Swinburne C; Hunter L; Giardini A; Christov G; Senniappan S; Banerjee I; Shaikh MG; Shah P
    Clin Endocrinol (Oxf); 2019 Dec; 91(6):770-775. PubMed ID: 31520536
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prolonged hyperinsulinaemic hypoglycaemia in newborns with intrauterine growth retardation.
    Fafoula O; Alkhayyat H; Hussain K
    Arch Dis Child Fetal Neonatal Ed; 2006 Nov; 91(6):F467. PubMed ID: 17056857
    [No Abstract]   [Full Text] [Related]  

  • 8. Delayed presentation of prolonged hyperinsulinaemic hypoglycaemia in a preterm small-for-gestational age neonate.
    Chong JH; Chandran S; Agarwal P; Rajadurai VS
    BMJ Case Rep; 2013 Dec; 2013():. PubMed ID: 24351577
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term treatment of persistent hyperinsulinaemic hypoglycaemia of infancy with diazoxide: a retrospective review of 77 cases and analysis of efficacy-predicting criteria.
    Touati G; Poggi-Travert F; Ogier de Baulny H; Rahier J; Brunelle F; Nihoul-Fekete C; Czernichow P; Saudubray JM
    Eur J Pediatr; 1998 Aug; 157(8):628-33. PubMed ID: 9727845
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term treatment with diazoxide in childhood hyperinsulinism.
    Grant DB; Dunger DB; Burns EC
    Acta Endocrinol Suppl (Copenh); 1986; 279():340-5. PubMed ID: 3465173
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ten years' experience of persistent hyperinsulinaemic hypoglycaemia of infancy.
    Tyrrell VJ; Ambler GR; Yeow WH; Cowell CT; Silink M
    J Paediatr Child Health; 2001 Oct; 37(5):483-8. PubMed ID: 11885714
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Randomised controlled trial of diazoxide for small for gestational age neonates with hyperinsulinaemic hypoglycaemia provided early hypoglycaemic control without adverse effects.
    Balachandran B; Mukhopadhyay K; Sachdeva N; Walia R; Attri SV
    Acta Paediatr; 2018 Jun; 107(6):990-995. PubMed ID: 29385640
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low-dose diazoxide is safe and effective in infants with transient hyperinsulinism.
    Malhotra N; Yau D; Cunjamalay A; Gunasekara B; S A; Gilbert C; Morgan K; Dattani M; Dastamani A
    Clin Endocrinol (Oxf); 2024 Feb; 100(2):132-137. PubMed ID: 38059644
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical presentation and treatment response to diazoxide in two siblings with congenital hyperinsulinism as a result of a novel compound heterozygous ABCC8 missense mutation.
    Galcheva S; Iotova V; Ellard S; Flanagan SE; Halvadzhiyan I; Petrova C; Hussain K
    J Pediatr Endocrinol Metab; 2017 Apr; 30(4):471-474. PubMed ID: 28328534
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Continuous treatment with diazoxide of hypoglycemia due to hyperinsulinism].
    Loyau G; Kopp J; Sauvalle A; Porin J
    Sem Hop; 1970 Jun; 46(27):1907-10. PubMed ID: 4316119
    [No Abstract]   [Full Text] [Related]  

  • 16. When is it best to discontinue diazoxide in children with persistent hyperinsulinaemic hypoglycaemia and negative genetics for K
    Güemes M; Kostopoulou E; AlYahyaei M; Gilbert C; Shah P
    Clin Endocrinol (Oxf); 2022 Feb; 96(2):107-113. PubMed ID: 34370339
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diazoxide for hyperinsulinism.
    Drug Ther Bull; 1970 Mar; 8(6):23-4. PubMed ID: 5440617
    [No Abstract]   [Full Text] [Related]  

  • 18. Transient lactic acidosis and hyperalaninaemia associated with neonatal hyperinsulinaemic hypoglycaemia: the effects of dichloroacetate (DCA).
    Aynsley-Green A; Weindling AM; Soltész G; Jenkins PA
    Eur J Pediatr; 1983 Dec; 141(2):114-7. PubMed ID: 6662140
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Congenital hyperinsulinism due to compound heterozygous mutations in ABCC8 responsive to diazoxide therapy.
    Taylor-Miller T; Houghton J; Munyard P; Kumar Y; Puvirajasinghe C; Giri D
    J Pediatr Endocrinol Metab; 2020 May; 33(5):671-674. PubMed ID: 32267248
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinical observations and experimental findings in the treatment of hyperinsulinism with diazoxide].
    Frerichs H; Creutzfeldt C; Creutzfeldt W
    Verh Dtsch Ges Inn Med; 1967; 73():1086-91. PubMed ID: 5591740
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.